ZYNE

Zynerba Pharmaceuticals, Inc

Delisted

ZYNE was delisted on the 10th of October, 2023.

77 hedge funds and large institutions have $35.3M invested in Zynerba Pharmaceuticals, Inc in 2020 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 24 reducing their positions, and 14 closing their positions.

Holders
77
Holders Change
-2
Holders Change %
-2.53%
% of All Funds
1.7%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
21
Reduced
24
Closed
14
Calls
$1.08M
Puts
$2.15M
Net Calls
-$1.07M
Net Calls Change
+$1.06M
Name Market Value Shares Shares
Change
Shares
Change %
AC
76
Aristides Capital
Kentucky
-26,518 Closed
GCP
77
GSA Capital Partners
United Kingdom
-22,106 Closed
Squarepoint
78
Squarepoint
New York
-17,254 Closed
ECM
79
ExodusPoint Capital Management
New York
-13,290 Closed
Capital Fund Management (CFM)
80
Capital Fund Management (CFM)
France
-11,775 Closed
Cetera Investment Advisers
81
Cetera Investment Advisers
Illinois
-10,800 Closed
ARTA
82
A.R.T. Advisors
New York
-10,272 Closed
Federated Hermes
83
Federated Hermes
Pennsylvania
-8,105 Closed
TRCT
84
Tower Research Capital (TRC)
New York
-4,250 Closed
AIC
85
Archer Investment Corporation
Indiana
-200 Closed
HR
86
Howe & Rusling
New York
-165 Closed
SFS
87
Sowell Financial Services
Arkansas
$0 80
CM
88
Caption Management
Oklahoma
Simplex Trading
89
Simplex Trading
Illinois
PA
90
Perceptive Advisors
New York
GT
91
Glenmede Trust
Pennsylvania
$0 50
CFGS
92
Concourse Financial Group Securities
Alabama
RFM
93
Royal Fund Management
Florida
$0 50
VNA
94
Valley National Advisers
Pennsylvania
$0 10 +10 New
OPS
95
Orion Portfolio Solutions
Nebraska
$0 20 +20 New
FWM
96
Filbrandt Wealth Management
Wisconsin
$0 75 +75 New